Discover how technology-forward innovation becomes commercial advantage. From selecting and integrating new technologies, to ensuring staff expertise, and delivering personalized treatments - learn how to maximize results, support recovery, and ensure strong returns.
Capitalize on the wellness revolution with proven revenue generation strategies for longevity services, energy-based devices, GLP-1 therapies, and IV drips. Stay ahead of fast-paced innovations and evolving consumer preferences while streamlining integration and navigating new trends.
Peter Cousins is the Chief Commercial Officer of Jeisys Medical North America, where he leads all U.S. commercial strategy and go-to-market execution for the global aesthetic device innovator. With more than 20 years of leadership experience in the aesthetic and medical device industries, Peter has held senior executive roles at companies including Thermage, Solta Medical, R2 Technologies, HintMD, Summus Medical Laser, and Patterson Dental.
Dr. Kay Durairaj is a board-certified facial plastic surgeon, educator, researcher, and practitioner who leads Beauty By Dr. Kay, a Pasadena-based aesthetic practice. She is recognized for her clinical expertise in facial rejuvenation, injectable techniques, liquid rhinoplasty, and bioregenerative therapies. Dr. Kay lectures internationally on practical, evidence-based approaches that bridge aesthetic medicine with longevity science.
She hosts the podcast “Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon,” where she interviews clinicians, scientists, and biohackers about skincare, injectables, and advances in anti-aging medicine. A seasoned international lecturer, she has delivered more than 50 national and international presentations and published clinical studies on biostimulators, AI in aesthetics, and injectables. Her research includes AI-assisted facial analysis and clinical trials on biostimulators, PDGF, and minimally invasive modalities. She serves on panels and organizes educational tracks at major meetings, emphasizing safety, measurable outcomes, and patient-centered protocols. Dr. Kay combines surgical skill with a systems approach to longevity and wellness.
Top insiders reveal behind-the-scenes insights on bold mergers, creative alliances, and disruptive MSO strategies. Gain quantifiable metrics from recent deals, practical tips on integration, and proven approaches for building scalable, sustainable value in a consolidating market.
Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group. Allison received a Bachelors of Science in Finance from The Wharton School of the University of Pennsylvania.
David Marks enjoys closing fast-paced, high-pressure deals by aligning economic interests on both sides of the transaction. His practice focuses on buy-side and sell-side private equity M&A, and he has extensive experience in healthcare and other industries. In recent years, Mr. Marks has played a key role in numerous middle-market healthcare transactions involving dental, dermatology, ophthalmology, optometry and optical, chiropractic and physical therapy, women's health, gastroenterology and other specialties.
Private equity clients, investors and sellers value his counsel in recapitalizations, add-on acquisitions and roll-ups. Additionally, Mr. Marks represents private equity firms, investors and privately held companies in sales of portfolio companies and investments involving PE acquirers. Clients benefit from his ability to bring deals to successful conclusions despite the challenges often posed by the complex financing structures and deadlines of private equity transactions.
Previously, Mr. Marks gained valuable experience as an associate in New York where he advised private equity firms, distressed businesses and major financial institutions in the design and implementation of sweeping operational and financial restructurings and M&A in some of the largest Chapter 11 cases in recent history.
Master the art of scaling with soul and strategy. Pinpoint how leading operators use demographic and economic data to target high-value geographies, secure smart real estate deals that reinforce brand identity, and navigate multi-state requirements to maximize returns.
Curate value-driven journeys that keep customers engaged, boost visit frequency, and inspire loyalty. Blend seamless member experiences, personalized perks, and feedback loops to strengthen your brand community and amplify advocacy, while building predictable long-term revenue.
From buzzword to business decision, explore the latest clinical evidence, regulatory realities, and ROI frameworks in regenerative aesthetics. Separating promises from proven outcomes, uncover if, when, and how exosomes fit your 2026 growth strategy.
Your systems should scale as fast as you do. Discover how inventory automation, AI forecasting, and smart procurement can cut waste, tighten control, and unlock hidden margin. Build a tech-powered operation that boosts profits and puts you ahead of the competition.
In an increasingly competitive field, harness AI-powered analysis, benchmarking intelligence, and precision pricing models for sustainable success. Convert insights into synchronised, margin-boosting playbooks that your teams can execute at scale across every location.
